- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2019
- Public Summary Document (PSD) March 2019 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2019 PBAC Meeting - Word
Buprenorphine – March 2019
Buprenorphine: Injection (modified release) 100 mg in 0.5 mL pre-filled syringe, Injection (modified release) 300 mg in 1.5 mL pre-filled syringe; Sublocade®
Last updated
19 July 2019